Partnership Opportunities
Strategic partnership allows the Foundation to contribute to the funding and development of larger, more intricate projects and networks which may fall outside the scope of our standard funding opportunities. These partnership opportunities help to leverage donor support, often increasing each donated dollar exponentially, to create a possibility of lasting impact.
Strategic partnership opportunities continue to represent an important priority for Foundational investment.
For information on partnership grant opportunities, please see below.
The following opportunities are currently available:
The Hyatt Family-Kidney Foundation Award for Kidney Health Innovation - OPENING SOON!
-
The Hyatt Family-Kidney Foundation Award for Kidney Health Innovation
The Kidney Foundation of Canada is pleased to partner with The Hyatt Family Foundation to support The Hyatt Family-Kidney Foundation Award for Kidney Health Innovation.
The Award for Kidney Health Innovation supports bold, high-impact research ideas focused on delaying or improving dialysis and enhancing transplantation for people living with kidney disease.
Funding details:
Number of awards available: 1
Total award amount: $600,000
Duration: 3 years
Objective and Scope
This grant is intended to support research that introduces cross-disciplinary concepts, novel hypotheses, or unconventional strategies to advance late-stage kidney care.
This competition is ideal for researchers or research teams with:
Ambitious ideas that may not fit within conventional funding programs.
Projects that have the potential to stimulate further investment or act as a platform for future high‑impact scientific or clinical breakthroughs.
Interdisciplinary teams or ideas that cross disciplinary lines.
Innovations that could shift clinical practice or transform patient outcomes.
Projects that seek to develop or could lead to commercially viable or clinically relevant outputs like tools, tests, devices, mechanisms, or care pathway innovations are encouraged.
Please read the award guidelines for more information (coming soon).
Applications from all disciplines are welcome and interdisciplinary collaboration is encouraged. Both established investigators and early‑career innovators are eligible to apply.
Areas of innovation could include (but are not limited to):
Transplantation and Organ Availability
Dialysis and Treatment Alternatives
Diagnostic or Clinical Tools
How to Apply
Coming soon
Key Dates:
Proposed, subject to change
Competition Launch: June 02, 2026
Letter of Intent Deadline: July 06, 2026
Application Deadline: September 04, 2026
Notification Date: March 01, 2027
Funding Start Date: July 01, 2027 (upon confirmation of REB approval)
Resources:
Coming soon
Grant Guidelines
Instructions-Letter of Intent (LOI)
Instructions-Full Application
Best Practices for Writing a Plain Language Abstract
Policy on Indirect Costs of Research
About the Hyatt Family Foundation
The Hyatt Family Foundation is dedicated to driving transformative, lasting change for children, youth, and families. We invest in strategic projects with high-impact potential, specifically advancing medical and healthcare innovation, supporting the long-term success and stability of families, and empowering women and girls through international development. We partner with mission-aligned organizations to scale community-led solutions and foster sustainable impact.
-
CDTRP Research Innovation Grants
The Kidney Foundation of Canada is pleased to partner with The Canadian Donation and Transplantation Research Program to support 2 innovation grants related to Kidney Donation and/or transplantation.
OBJECTIVES AND SCOPE
The primary objective of the CDTRP Research Innovation Grant competition is to support new peer-reviewed pilot research projects that align with CDTRP’s mission, which is to drive advances in Canadian donation and transplantation research and mobilize knowledge so that every wish to donate is fulfilled and transplantation is transformed from a treatment to a lasting and sustainable cure.
These projects must be new stand-alone studies that align with one of the 5 Themes of the CDTRP and should be used to generate preliminary data to support further investigation.
The five CDTRP Themes are:
1. Improve a culture of donation
2. Inform universal practices for donation
3. Engineer and allocate a better graft
4. Tailor an optimal immune system for each patient
5. Restore long-term health
Grant recipients are expected to integrate their proposed study within the CDTRP research structure. The total value of the competition is $270,000, enough to support 9 grants of $30,000 CAD each (pending availability of partner funding).
KEY DATES: CLOSED
Competition Launch: January 20, 2026
Application Deadline: April 1, 2026
Notification Date: July 2026
Funding Start Date: July 2026 (upon confirmation of REB approval)
Study update submitted to CDTRP: Within 18 months of Funding Start Date
For more information please see: CDTRP Research Innovation Grant Competition – Canadian Donation and Transplantation Research Program. -
CIHR Team Grants: Embracing Diversity to Achieve Precision and Increase Health Equity
The Kidney Foundation of Canada is pleased to announce our partnership in this innovative initiative from The Canadian Institutes of Health Research; Team Grants: Embracing Diversity to Achieve Precision and Increase Health Equity.
The Kidney Foundation of Canada is dedicated to improving kidney health for all Canadians, and supporting groundbreaking research which embraces the diversity of the Canadian population is key to increasing health equity and inclusion for all.
To see details of the announcement please visit:
https://researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=4025 -
Alport Syndrome Research Funding Program
Alport Syndrome Research Funding Program - CLOSED
Offered in conjunction with the Pedersen Family and the Alport Syndrome Foundation Inc. (ASF), the principal goal of this funding program is the development of novel treatments to prevent kidney failure and hearing loss in patients with Alport Syndrome.
Letters of intent will be evaluated by an independent peer review process. They should be no longer than 2 pages in length and must be in accordance with the instructions detailed in the ASF & Partners Alport Syndrome Research Funding Program. Authors found to have the best merit for funding will be invited to submit a full proposal application 10–15 pages in length for further independent peer review. Final grant recipients will be selected from this pool. There are no geographical limitations for this funding.
RESOURCES:
Letter of Intent Guidelines and Requirements